googlemarker
Open An Account
Secure With Us
Refer a Friend
Advisory For Investors
Trade on Mobile

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 1262860.58 Face Value (Rs.) : 2 House : Divis Labs
BSE4757.10-20.9 (-0.44 %)
PREV CLOSE (Rs.) 4778.00
OPEN PRICE (Rs.) 4800.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16098
TODAY'S LOW / HIGH (Rs.)4715.50 4800.00
52 WK LOW / HIGH (Rs.)3154.5 5425
NSE4757.05-20.25 (-0.42 %)
PREV CLOSE( Rs. ) 4777.30
OPEN PRICE (Rs.) 4797.30
BID PRICE (QTY) 4757.05 (11)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 300986
TODAY'S LOW / HIGH(Rs.) 4713.60 4797.35
52 WK LOW / HIGH (Rs.)3153.3 5425.1
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
765.80
Dividend Yield(%)
0.42
TTM EPS (Rs.)
79.39
P/E Ratio
59.92
Book Value (Rs.)
372.89
Face Value (Rs.)
2
MCap (Rs. in Mn)
1262860.58
Price/Earning (TTM)
52.72
Price/Sales (TTM)
17.32
Price/Book (MRQ)
12.76
PAT Margin (%)
28.66
ROCE (%)
31.64
Incorporation Year : 12-10 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 2378 6300

Website : www.divislabs.com

Registrars Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
08Nov Divi's Laboratories reports 17% rise i
Divi's Laboratories has reported results for second quarter ended Septem..
06Nov Divis Laboratories informs about outco
Divis Laboratories has informed that the Board of Directors of the Compa..
02Nov Divi’s Laboratories informs about earn
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
QTR Sep 21 ANNUAL 21
Net Profit6063.919547.2
Gross Profit 7604.4 26278.7
Operating Profit 8377 28832.1
Net Sales 19678.6 67986.1
Rs. in Millions
Medicamen Biotech (BSE)
img  699.50 (16.65%)
M.Cap (Rs. in Cr)854.55
Hester Biosciences (BSE)
img  2346.25 (4.12%)
M.Cap (Rs. in Cr)1995.92
Kwality Pharma (BSE)
img  905.50 (5.00%)
M.Cap (Rs. in Cr)939.56
Glaxosmithkline Phar (BSE)
img  1732.10 (2.23%)
M.Cap (Rs. in Cr)29342.82
PROMOTERS
51.95%
MUTUAL FUNDS/UTI
12.63%
NON-INSTITUTION
11%
FI/BANKS/INSURANCE
0%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
● Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020.     ● Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.     ● Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.    .......... Issued in the interest of Investors          
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     2239816